March 26 (Reuters) - Federal prosecutors in Manhattan
are probing a claim brought by GSK that Pfizer ( PFE )
delayed announcing the success of its COVID-19 vaccine in 2020
until after that year's election, the Wall Street Journal
reported on Wednesday, citing people familiar with the matter.